Jury Awards Scientist $6 Million in Defamation Case Against MIT Over Misconduct Claims
A Massachusetts jury's verdict vindicates scientist David Sabatini, who had his career ended by sexual misconduct allegations that a jury later rejected.
A jury has awarded scientist David Sabatini $6 million after rejecting sexual misconduct claims that led to the end of his career at the Massachusetts Institute of Technology (MIT) and the closure of his research laboratory at the Whitehead Institute. The verdict, delivered by a jury of seven women and six men, offered a measure of objectivity to the facts of the case that the leadership of MIT and Whitehead had not provided, according to the lawsuit's reporting.
Sabatini, once a highly regarded molecular cell biologist, had his career derailed following accusations from former colleague Kristin Knouse. Evidence presented at trial suggested Knouse initiated a campaign she termed "covert operation dethrone" after Sabatini ended their relationship. Messages attributed to Knouse indicated an intent to portray Sabatini in a manner akin to disgraced movie producer Harvey Weinstein and expressed a desire for retribution.
Knouse reported Sabatini to Whitehead's director, Ruth Lehmann, in the fall of 2020, alleging harassment and assault. Trial testimony suggested Lehmann was receptive to the claims, with Knouse reporting Lehmann seemed eager to find a reason to fire Sabatini. Lehmann denied making specific comments about wanting to fire Sabatini.
Whitehead engaged a law firm to investigate, but the investigation's outcome appeared predetermined, according to reporting and trial evidence. The firm's final report did not conclude whether the relationship between Sabatini and Knouse was consensual. Instead, it faulted Sabatini for not reporting the relationship to human resources and for a "sexualized undercurrent" in his lab, deeming both violations of an anti-harassment policy. The report also criticized Sabatini's focus on "science above all else."
Following the report, the Howard Hughes Medical Institute terminated Sabatini's employment. He resigned from Whitehead after being informed of the institute's intent to dismiss him.
At MIT, a committee convened to consider Sabatini's tenure, including MIT's dean of science, Nergis Mavalvala. Trial testimony indicated the committee did not interview former members of Sabatini's lab, including 34 who had written in his support. In early 2022, the committee recommended revoking Sabatini's tenure, leading to his resignation under pressure.
Emails introduced at trial showed Mavalvala expressing alignment with Lehmann's approach to the case, referring to Lehmann as being "at the vanguard of cultural change." Mavalvala later testified that her "alignment" with Lehmann concerned procedural matters, not the desired outcome for Sabatini's case, a statement the jury reportedly reacted to with laughter.
Sabatini now leads a lab in Prague and a related lab in Boston. Knouse continues to direct a lab at MIT and recently received a grant from the National Institutes of Health. Lehmann and Mavalvala remain in their positions at Whitehead and MIT, respectively.
The verdict has raised questions about the role of diversity, equity, and inclusion (DEI) initiatives in academic institutions and their potential impact on scientific research and due process. The lawsuit's author suggests that an investigation into the "weaponization of DEI" is warranted, asserting that institutions receiving significant public funding should be accountable for how those funds are used and the decisions made concerning their personnel.